This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Double Blind, Randomised, placebo-contoled Trial...
Clinical trial

A Double Blind, Randomised, placebo-contoled Trial to establish the safety and efficacy of a probiotic in subjects with Irritable Bowel Syndrome

Read time: 1 mins
Last updated:9th Sep 2009
The main efficacy variable will be; Responder Rates for adequate relief of abdominal pain/discomfortesponder and Rates for adequate relief of IBS symptoms
Category Value
Study start date 2009-09-09

View full details